These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6. Peters M; Blinn G; Solem F; Fischer M; Meyer zum Büschenfelde KH; Rose-John S J Immunol; 1998 Oct; 161(7):3575-81. PubMed ID: 9759879 [TBL] [Abstract][Full Text] [Related]
5. The IL-6/sIL-6R treatment of a malignant melanoma cell line enhances susceptibility to TNF-alpha-induced apoptosis. Wagley Y; Yoo YC; Seo HG; Rhee MH; Kim TH; Kang KW; Nah SY; Oh JW Biochem Biophys Res Commun; 2007 Mar; 354(4):985-91. PubMed ID: 17274948 [TBL] [Abstract][Full Text] [Related]
6. I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Fischer M; Goldschmitt J; Peschel C; Brakenhoff JP; Kallen KJ; Wollmer A; Grötzinger J; Rose-John S Nat Biotechnol; 1997 Feb; 15(2):142-5. PubMed ID: 9035138 [TBL] [Abstract][Full Text] [Related]
7. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice. Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646 [TBL] [Abstract][Full Text] [Related]
8. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Finotto S; Eigenbrod T; Karwot R; Boross I; Doganci A; Ito H; Nishimoto N; Yoshizaki K; Kishimoto T; Rose-John S; Galle PR; Neurath MF Int Immunol; 2007 Jun; 19(6):685-93. PubMed ID: 17496315 [TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121 [TBL] [Abstract][Full Text] [Related]
11. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436 [TBL] [Abstract][Full Text] [Related]
12. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage. Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045 [TBL] [Abstract][Full Text] [Related]
13. Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Peters M; Blinn G; Jostock T; Schirmacher P; Meyer zum Büschenfelde KH; Galle PR; Rose-John S Gastroenterology; 2000 Dec; 119(6):1663-71. PubMed ID: 11113088 [TBL] [Abstract][Full Text] [Related]
14. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors. Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033 [TBL] [Abstract][Full Text] [Related]
15. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Nakama T; Hirono S; Moriuchi A; Hasuike S; Nagata K; Hori T; Ido A; Hayashi K; Tsubouchi H Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Camargo CA; Madden JF; Gao W; Selvan RS; Clavien PA Hepatology; 1997 Dec; 26(6):1513-20. PubMed ID: 9397992 [TBL] [Abstract][Full Text] [Related]
17. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Migita K; Abiru S; Maeda Y; Daikoku M; Ohata K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H Hum Immunol; 2006; 67(1-2):27-32. PubMed ID: 16698422 [TBL] [Abstract][Full Text] [Related]
18. Hepatic regeneration induces transient acute phase reaction: systemic elevation of acute phase reactants and soluble cytokine receptors. Fulop AK; Pocsik E; Brozik M; Karabelyos C; Kiss A; Novak I; Szalai C; Dobozy O; Falus A Cell Biol Int; 2001; 25(7):585-92. PubMed ID: 11448096 [TBL] [Abstract][Full Text] [Related]
19. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture. Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637 [TBL] [Abstract][Full Text] [Related]
20. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury. Katz MS; Thatch KA; Schwartz MZ J Surg Res; 2010 Oct; 163(2):294-8. PubMed ID: 20691983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]